Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brynn B Duncan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|September 26, 2022
Applying a clinical lens to animal models of CAR-T cell therapiesBrynn B Duncan, Cynthia E Dunbar, Kazusa Ishii
Current Hematologic Malignancy Reports|August 19, 2018
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory DiseaseKatherine C Pehlivan, Brynn B Duncan, Daniel W Lee
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2013
Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosisChristian M Capitini, Nicole M Nasholm, Brynn B Duncan, et al.
Cancer Metastasis Reviews|December 14, 2024
Evolving strategies for addressing CAR T-cell toxicitiesAlexander W Rankin, Brynn B Duncan, Cecily Allen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 8, 2022
Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and ChemotherapySeena Tabibi, Sonia Kamanda, Nicolas Llosa, et al.
British Journal of Haematology|March 11, 2024
Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopagBrynn B Duncan, Jennifer L Lotter, Jeanine Superata, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2025
Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cellsTaha B Hayal, Aman A Mulla, David S J Allan, et al.
Vaccine|April 16, 2014
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccinesRenee N Donahue, Brynn B Duncan, Terry J Fry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyBrynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|September 26, 2022
Applying a clinical lens to animal models of CAR-T cell therapiesBrynn B Duncan, Cynthia E Dunbar, Kazusa Ishii
Current Hematologic Malignancy Reports|August 19, 2018
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory DiseaseKatherine C Pehlivan, Brynn B Duncan, Daniel W Lee
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2013
Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosisChristian M Capitini, Nicole M Nasholm, Brynn B Duncan, et al.
Cancer Metastasis Reviews|December 14, 2024
Evolving strategies for addressing CAR T-cell toxicitiesAlexander W Rankin, Brynn B Duncan, Cecily Allen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 8, 2022
Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and ChemotherapySeena Tabibi, Sonia Kamanda, Nicolas Llosa, et al.
British Journal of Haematology|March 11, 2024
Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopagBrynn B Duncan, Jennifer L Lotter, Jeanine Superata, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2025
Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cellsTaha B Hayal, Aman A Mulla, David S J Allan, et al.
Vaccine|April 16, 2014
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccinesRenee N Donahue, Brynn B Duncan, Terry J Fry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyBrynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Pageof 1